Skip to main content
TipRanks
Go Ultimate75% OFF

YSB Inc. (9885) AI Stock Analysis

1 Followers
HK:9885

YSB Inc.

(HKEX:9885)

Select Model
Rating:63Neutral
Price Target:HKD 3.00â–²(8.11% Upside)
Action:reiterated
Date:11/19/26

Solid financial performance with revenue growth and cash flow, plus attractive valuation from low P/E and dividend yield, are the primary drivers; technical weakness from bearish momentum provides a partial offset.

Positive Factors
Revenue and Profit TurnaroundSteady revenue expansion into 2025, combined with a return to positive EBIT and net income, indicates improving operating scale and business performance. If sustained, the turnaround can strengthen internal funding capacity and provide a more durable base for future growth.
Negative Factors
Very Thin MarginsVery thin gross and net margins leave little earnings cushion if costs rise or pricing becomes less favorable. This limits the company’s ability to absorb operating pressure, makes reported profitability more sensitive to small changes, and may constrain reinvestment capacity.

YSB Inc. (9885) vs. iShares MSCI Hong Kong ETF (EWH)

-60%-40%-20%0%20%HK:9885-58.19%EWH+9.93%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
HKD 1.78B
Dividend Yield
4.50%
Average Volume (3M)
696.56K
Price to Earnings (P/E)
8.9
Beta (1Y)
0.44
Revenue Growth
16.99%
EPS Growth
126.15%
Country
Hong Kong
Employees
6,950
Sector
Healthcare
Sector Strength
51
Industry
Software - Application

YSB Inc. Business Overview & Revenue Model

Company Description

YSB Inc. provides a comprehensive digital platform tailored for the Chinese pharmaceutical sector, supporting a wide array of stakeholders such as drug companies, distributors, vendors, pharmacies, and primary healthcare facilities. Its key offerings...

YSB Inc. Financial Statement Overview

Summary

Revenue growth and strong cash flow generation support operations, though thin margins and elevated debt-to-equity ratio remain concerns.

Income Statement

65Positive

Balance Sheet

55Neutral

Cash Flow

75Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue21.27B20.97B17.90B16.97B14.27B10.09B
Gross Profit2.34B2.31B1.81B1.74B1.43B913.83M
EBITDA254.12M215.85M32.88M-3.07B-1.35B-392.32M
Net Income184.16M152.97M30.01M-3.21B-1.50B-501.62M
Balance Sheet
Total Assets7.39B7.57B6.50B5.21B4.11B3.44B
Cash, Cash Equivalents and Short-Term Investments3.00B3.38B1.99B1.83B1.87B1.14B
Total Debt2.44B2.77B233.51M209.66M180.55M181.73M
Total Liabilities5.06B5.18B4.23B3.33B8.48B6.35B
Stockholders Equity2.38B2.44B2.32B1.92B-4.35B-2.90B
Cash Flow
Free Cash Flow655.93M619.46M632.46M433.65M54.49M-608.06M
Operating Cash Flow688.97M637.70M655.86M451.20M98.20M-487.09M
Investing Cash Flow-229.17M-896.27M-253.58M-792.95M41.07M-352.80M
Financing Cash Flow-255.91M-70.97M-109.81M255.34M261.93M1.12B

YSB Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price2.77

Price Trends

50DMA3.40Negative
100DMA3.51Negative
200DMA3.98Negative

Market Momentum

MACD-0.10Positive
RSI17.03Positive
STOCH28.85Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9885, the sentiment is Negative. The current price of 2.77 is below the 20-day moving average (MA) of 3.36, below the 50-day MA of 3.40, and below the 200-day MA of 3.98, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 17.03 is Positive, neither overbought nor oversold. The STOCH value of 28.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:9885.

YSB Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:9885 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1588HK:158882OutperformHKD 1.78B16.799.51%8.10%21.19%19.81%
HK:0268HK:026872OutperformHKD 29.64B100.313.02%―16.98%―
HK:8083HK:808369NeutralHKD 1.43B2.9412.42%―8.65%―
HK:9885HK:988563NeutralHKD 1.89B8.887.63%4.50%16.99%126.15%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:6657HK:665747NeutralHKD 3.25B-30.73-6.21%―-3.42%-13.93%
HK:2013HK:201339UnderperformHKD 2.25B-5.22-13.18%―40.17%76.39%

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%HK:9885HK:8083HK:0268HK:2013HK:1588HK:6657Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HK:9885 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:9885YSB Inc.2.77-3.96-58.79%
HK:8083China Youzan 0.98-2.47-71.52%
HK:0268Kingdee International Software Group Co 8.19-5.95-42.08%
HK:2013Weimob 0.55-1.46-72.75%
HK:1588Chanjet Information Technology Co., Ltd. Class H5.53-2.25-28.96%
HK:6657Baiwang Co., Ltd. Class H9.01-8.39-48.25%

YSB Inc. Corporate Events

YSB Inc. Clarifies Share Incentive Plan Details Across 2023–2025 Reports

Sep 22, 2026

YSB Inc. has issued a supplemental announcement to its annual reports for 2023, 2024 and 2025, providing additional disclosure on its 2023 Share Incentive Plan as required under Hong Kong Listing Rules. The update focuses on the service provider subl...

YSB Inc. Clarifies Performance Undertaking Linked to Acquisition

Sep 22, 2026

YSB Inc. has issued a supplemental announcement clarifying the implications of a new three-year performance undertaking linked to its previously disclosed acquisition of a target company. The company states that failure to meet these performance targ...

YSB Inc. Delivers Profit Surge as Digital Pharma Platform Deepens Market Reach

Aug 20, 2026

YSB Inc. reported unaudited interim results for the six months ended June 30, 2026, showing revenue of RMB10.28 billion, up 4.5% year-on-year, driven mainly by a 5.3% rise in its self-operation business. Profit attributable to owners surged 41.9% to...

YSB Inc. Buys HK$158 Million in Shares to Fund Incentive Plan

Aug 20, 2026

YSB Inc. has disclosed that a trustee acting under its 2023 share incentive plan purchased 35,365,600 shares on the market between March 23 and July 21, 2026, at a total consideration of HK$158.8 million and an average price of about HK$4.49 per shar...

YSB Inc. Launches Discretionary Share Buyback Plan Under 2026 Mandate

Aug 20, 2026

YSB Inc. has unveiled a voluntary share repurchase plan under its existing 2026 general mandate, authorising buybacks of up to 10% of its issued share capital, capped at HK$100 million and executed on the open market. The company will fund the repurc...

YSB Inc. Reports Integration Progress and Management Commitment on Key Acquisition

Aug 20, 2026

YSB Inc. reported progress on integrating a recently acquired target company, highlighting efforts to unify business processes, systems, organizational structures and digital operations. Management emphasized that synergy in supply chain and digital...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026